Firox™ (firocoxib) Chewable Tablets are indicated for the control of pain and inflammation associated with osteoarthritis and for the control of postoperative pain and inflammation associated with soft-tissue and orthopedic surgery in dogs.
When compared to the pioneer, Firox is a cost-effective alternative that makes it easier to boost your profit potential while also passing greater savings along to your clients.
- Scored for easy splitting and accurate dosing of 5 mg/kg (2.27 mg/lb) body weight, once daily
- Available in 57 mg and 227 mg strengths
- Available in 60 count and economical 180 count bottles
- Chewable tablet with pork-liver flavoring
- Can be given with or without food
Proven Pain Relief
In a study of 1,000 dogs diagnosed with OA, 93% of dog owners rated their dog as “improved” and 86% of dog owners rated their dog as “happier” or “more active” after treatment with firocoxib.3
1 McCann M, Andersen D, Zhang D, et al. In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in dogs with experimentally induced synovitis. AJVR 2004;65(4):503–512.
2 Data on file.
3 Ryan WG, Moldave K, Carithers D. Clinical effectiveness and safety of a new NSAID, firocoxib: a 1,000 dog study. Vet Ther. 2006;7(2):119–126.
IMPORTANT SAFETY INFORMATION: FIROX (firocoxib) Chewable Tablets are for use in dogs only. As a class, cyclooxygenase inhibitory NSAIDs like FIROX may be associated with gastrointestinal, kidney, or liver side effects. Dogs should be evaluated for pre-existing conditions and currently prescribed medications prior to treatment with FIROX, then monitored regularly while on therapy. Concurrent use with another NSAID, corticosteroid, or nephrotoxic medication should be avoided or monitored closely. For more information, please see full prescribing information.
© 2023 Norbrook Laboratories Limited. The Norbrook logo is a registered trademark and Firox is a trademark of Norbrook Laboratories Limited. Previcox is a registered trademark of Boehringer Ingelheim Animal Health USA Inc.